It is crucial to discuss your age with a healthcare professional to ensure the dosage is adjusted accordingly for optimal results
Follow-Up Care and Documentation : Post-surgery, individuals must adhere to recommended follow-up care and provide ongoing documentation of their progress to Tricare
The value of optimizing endogenous GLP-1 (and partner hormones) for all patients Differentiating key nutritional needs for patients taking GLP-1 agonists, and those weaning off of them
Why Proper Diagnosis is Critical Its very important to diagnose B12 deficiency correctly to avoid long-term damage
January 16, 2026: As Zepbound Drives Eli Lillys Revenue, More People File Lawsuits Claiming Injuries from the Drug In the federal MDL, there are 3,063 pending lawsuits against Eli Lilly and other GLP-1 drug makers (as of January 5, 2026)
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two distinct indications: type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
